Patents by Inventor Michelle E. Leblanc

Michelle E. Leblanc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220356237
    Abstract: Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-binding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.
    Type: Application
    Filed: June 29, 2022
    Publication date: November 10, 2022
    Inventors: Wei Li, Michelle E. Leblanc, Weiwen Wang, Philip J. Rosenfeld
  • Patent number: 11414482
    Abstract: Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-binding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: August 16, 2022
    Assignee: UNIVERSITY OF MIAMI
    Inventors: Wei Li, Michelle E. Leblanc, Weiwen Wang, Philip J. Rosenfeld
  • Publication number: 20190315848
    Abstract: Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-bin ding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.
    Type: Application
    Filed: November 6, 2017
    Publication date: October 17, 2019
    Inventors: Wei Li, Michelle E. Leblanc, Weiwen Wang, Philip J. Rosenfeld